Seminer 3

28 Mart 2017

Dr. Yilmazer “Transfection of human melanoma cells with reprogramming factors (OKSM) alters cancer-related pathways and tumorigenicity” başlıklı sunumunu İspanya – Madrid’de 6. International Conference and Exhibition on Cell and Gene Therapy konferansında verdi.